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Short Communication
The prevalence of medical reasons for
non-participation in the Scottish breast and
bowel cancer screening programmes
L Mead1, L Porteous2, M Tait3, R Stoker4, S Payne5, C Calvert6,
D Maxwell7 and SV Katikireddi8
Abstract
Objective: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may
not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean
participation would be inappropriate. This study aims to quantify the proportion of non-participants who have a medical reason
for not attending cancer screening.
Methods: Medical reasons for not participating in breast and bowel screening were defined a priori on the basis of
a literature review and expert opinion. The notes of 700 patients at two GP practices in Scotland were reviewed, to
ascertain the prevalence of medical reasons amongst non-participants. Simple proportions and confidence intervals were
calculated.
Results: 17.4% of breast and 2.3% of bowel screening non-participants had a medical reason to not participate. The two most
common reasons were previous breast cancer follow up (8.86%) and recent mammogram (6.57%).
Conclusion: These patients may not benefit from screening while also being distressed by receiving an invitation. This issue
also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly
the extent to which medical reasons account for screening non-participation in a larger population.
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Introduction
Cancer screening programmes internationally often
experience challenges in maximizing uptake.1–3 In
Scotland, breast screening (via three-yearly mammog-
raphy) and colorectal cancer screening (involving biennial
faecal occult blood testing) have uptake rates of 74.5%
and 54.9% respectively. Improving screening uptake for
these two programmes has been prioritized by the Scottish
Government’s Detect Cancer Early campaign.4,5 The
many reasons why people do not attend screening include
fear of results and not liking the test.6,7 Feedback from
clinicians locally suggested that some invited participants
have a speciﬁc medical reason for not being screened. This
could mean that screening would be inappropriate (eg. if
the patient is being treated palliatively for a terminal con-
dition), or that greater surveillance is already being under-
taken and so screening programme participation is not
necessary. This study aims to quantify the percentage of
patients in two Scottish GP practices with medical reasons
for non-participation in breast and bowel screening
programmes.
Methods
Case notes were analyzed from 700 patients who had not
participated in the previous round of breast or bowel
screening. The sample size was chosen to allow reasonable
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precision of estimates. These patients were registered to
one of two GP practices: practice one, located in an aﬄu-
ent area, with a ‘‘Scottish Index of Multiple Deprivation’’
score in the least deprived quintile with around 11,000
patients, and practice two, located in the middle quintile
for deprivation, but where over half of the around 12,500
patients are in the two most deprived quintiles. The
patients were randomly selected from non-participants in
the 2012 bowel screening programme and from the most
recent (2009–2012) breast screening programme.
There is no clear guidance on what is considered a med-
ical reason not to be invited for screening in Scotland, so
criteria were deﬁned by local experts before data collection.
For breast screening medical reasons were considered to be:
bilateral mastectomy, recent mammogram (within the last 6
months), pregnancy, familial screening, terminal illness, lack
of capacity to undergo screening, and cancer follow-up. For
bowel screening, medical reasons were: no functioning
bowel, recent colonoscopy, familial screening, terminal ill-
ness, lack of capacity to undergo screening (ie. a doctor
deemed the invitation inappropriate), and cancer follow-
up. Patients who had moved or died were excluded because
the electronic notes available were not adequate to deter-
mine if there was a medical reason for non-participation.
Conﬁdence intervals based on proportions were calculated
using Minitab (v 16).
Results
Of the 700 non-respondents, 69 patients had a medical
reason for not participating (Table 1). Of those with a
medical reason, the largest two groups for both breast
and bowel screening were current follow-up for breast
cancer with 8.86% (95% CI: 6.10, 12.3) and recent inves-
tigation (mammogram) with 6.57% (95% CI: 4.21, 9.70).
Other reasons accounted for a much smaller percentage
(from 0.29% to 1.14%). The largest group in each screen-
ing programme was ‘‘no medical reason’’, with 82.6%
(95% CI: 78.2, 86.4) breast screening non-participants
and 97.7% (95% CI: 95.6, 99.0) of bowel screening non-
participants. Rates did not diﬀer signiﬁcantly between
practices (results not shown).
Discussion
This study demonstrated that there are patients who have
medical reasons that mean it may not be appropriate for
them to be invited for either breast or bowel screening.
There was a much greater number of patients who were
potentially inappropriately invited for screening amongst
breast cancer screening patients (17.4%) compared with
bowel cancer screening patients (2.3%). These ﬁgures are
less disparate when considering that 26.5% of those
invited do not attend Breast screening compared with
45.1% for Bowel screening.4,5 Patients with a medical
reason for not participating represent 4.6% of the total
number of people invited for breast screening and 1.04%
for bowel screening.
This is the ﬁrst study to quantify the number of patients
with a medical reason for not participating in either breast
or bowel cancer screening. A previous study in
Birmingham, aiming to increase breast cancer screening
uptake, identiﬁed 548 persistent non-attenders and invited
them to attend for screening, of whom 482 gave a
response.8 It was found that eight women (1.66%) had
recently had a mammogram and three (0.62%) were
under care for other conditions. These ﬁgures are not dir-
ectly comparable with the estimated 8.86% of non-parti-
cipants in our study who were still in hospital follow-up
and 6.57% had recently had a mammogram, most likely
reﬂecting diﬀerences in study design. No similar studies
were identiﬁed for bowel screening.
Our study was in a small population and would need to
be replicated using a larger sample of representative prac-
tices across Scotland to gain more meaningful results.
However, it establishes the principle that non-participation
Table 1. Medical reasons for non-participation in the Scottish 2009–2012 breast screening and 2012 bowel screening in a random sample of
non-participants in two GP practices in the Edinburgh and the surrounding area. Total N¼ 700.
Breast Bowel
N % N %
No medical reason 289 82.6 (95% CI: 78.2, 86.4) 342 97.7 (95% CI: 95.6, 99.0)
Hospital follow up 31 8.86 (95% CI: 6.10, 12.3) 4 1.14 (95% CI: 0.31, 2.90)
Recent investigationA 23 6.57 (95% CI: 4.21, 9.70) 2 0.57 (95% CI: 0.07, 2.05)
Familial screening 4 1.14 (95% CI: 0.31, 2.90) 0 0
Previous surgeryB 2 0.57 (95% CI: 0.07, 2.05) 1 0.29 (95% CI: 0.01, 1.58)
Lack of capacity to undergo screeningC 1 0.29 (95% CI: 0.01, 1.58) 1 0.29 (95% CI: 0.01, 1.58)
Terminal illness 0 0 0 0
Total 350 350
A¼ either colonoscopy or mammogram within 6 months.
B¼ either bilateral mastectomy or total colectomy.
C¼ Patients without capacity to decide to participate in screening, whose healthcare team concluded not being screened is in their best interest.
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for medical reasons could be important and require further
investigation.
Despite this study’s limitations, the results are of high
policy relevance.9 Identifying patients who should not be
invited for breast and bowel screening would allow more
accurate monitoring of the eﬀect of interventions to
increase attendance. It is also important to consider the
psychological impact invitation for screening could have
on patients with medical reasons for non-participation,
and to reduce the risk of this occurring as much as pos-
sible.10 Clear guidelines on medical reasons that mean a
patient should not be invited for screening are necessary.
Currently only patients ﬁtting very strict exclusion cri-
teria (ie. have had a bilateral mastectomy or are terminally
ill) are not invited for breast screening in Scotland. If the
details of patients being followed-up for breast cancer, or
patients who have recently had a mammogram could be
sent to the breast-screening centres, 78% of patients
deemed to have been inappropriately invited for breast
screening in this study would not have been invited.
Conclusion
This study demonstrates that patients with medical reasons
for not being screened are present in both the breast and
bowel screening programmes in two GP practices in
Edinburgh and the surrounding area. Potential to prevent
inappropriate oﬀers for screening exists, but further work is
needed to calculate the extent to which medical reasons
account for screening non-participation in a larger represen-
tative population.
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